LAUREN LENAUER: Open Payments
NPI 1316559255 · COLUMBIA, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$646 in 34 payments from 13 companies in 2025. Trend: 2023 $189 · 2024 $583 · 2025 $646
Food & beverage: $646
| Company | Payments | Amount |
|---|---|---|
| BIOTRONIK INC. | 7 | $125 |
| Novartis Pharmaceuticals Corporation | 5 | $96 |
| Novo Nordisk Inc | 3 | $76 |
| Amgen Inc. | 4 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| CVRx, Inc. | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 2 | $33 |
| Merck Sharp & Dohme LLC | 1 | $27 |
| GENZYME CORPORATION | 1 | $23 |
Products named: BIOMONITOR, LEQVIO, Wegovy, REPATHA, ELIQUIS, WAINUA, Barostim Neo System, AMVUTTRA.
Industry payments across MO — which companies pay providers there.
